Back to search
Pelvic Toxicity
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Pelvic Toxicity trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Pelvic Toxicity trials you may qualify forThis early phase I trial compares the side effects between patients treated with proton radiation therapy versus intensity modulated radiation therapy after sur…
The purpose of this study is to examine the feasibility of adding pre-rehabilitation pelvic health physical therapy to standard of care radiation therapy treatm…
This research is to determine if an oral probiotic, Pendulum Glucose Control (PGC), can be safely given to patients during pelvic radiation therapy (RT). The re…
The standard treatment of high-risk prostatic adenocarcinoma is based on pelvic-prostatic external radiotherapy combined with concomitant and adjunctive hormone…
Gynecological cancers, including those affecting the ovaries, uterus, and cervix, represent a significant health burden for women. While survival rates have imp…
Background: \- Gemcitabine and carboplatin are chemotherapy drugs used to treat several types of cancer, including cancer of the pancreas, bladder, ovaries, an…
Post-operative radiotherapy is internationally accepted as standard practice in the management of high-risk endometrial cancer1. Whilst it has no proven impact…